About this trial
The purpose of this study is to collect data on blood circulation using a multi-frequency impedance plethysmography device developed in the ThrombUS+ project. Impedance plethysmography (IPG) is a non-invasive method that measures changes in blood volume using electrodes placed on the skin. The collected data will be used for device development, the improvement of diagnostic data analysis methods, and AI training.
A total of 40 participants will be recruited for this study, with 20 healthy volunteers in Tampere University and 20 patients undergoing thrombolytic therapy for DVT at Tampere University Hospital.
Eligibility criteria
Qualifiers
Age: 18 or older;
DVT detected on other lower limb;
Suitable for CDT treatment;
Ability to give informed consent;
Disqualifiers
Age under 18 years;
Inability to give informed consent;
Denial;
Too injured skin in the measurement area
Trial design
Treatments tested in this trial
- Impedance plethysmography IPG
- Venous Occlusion Plethysmography VOP
- Breathing and leg movement exercise
Treatment groups
Sponsors and collaborators
Tampere University
Lead sponsor
Tampere University Hospital
Collaborator